Skip to Content
Merck
CN

Repurposing FDA-approved drugs for anti-aging therapies.

Biogerontology (2016-08-04)
Terry W Snell, Rachel K Johnston, Bharath Srinivasan, Hongyi Zhou, Mu Gao, Jeffrey Skolnick
ABSTRACT

There is great interest in drugs that are capable of modulating multiple aging pathways, thereby delaying the onset and progression of aging. Effective strategies for drug development include the repurposing of existing drugs already approved by the FDA for human therapy. FDA approved drugs have known mechanisms of action and have been thoroughly screened for safety. Although there has been extensive scientific activity in repurposing drugs for disease therapy, there has been little testing of these drugs for their effects on aging. The pool of FDA approved drugs therefore represents a large reservoir of drug candidates with substantial potential for anti-aging therapy. In this paper we employ FINDSITE

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Enoximone, solid